cbx3 polyclonal antibody (Proteintech)
Structured Review

Cbx3 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cbx3+polyclonal+antibody/CBX3+Antibody/pmc09019303-82-15-18
Average 93 stars, based on 30 article reviews
Images
1) Product Images from "Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer"
Article Title: Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
Journal: Frontiers in Genetics
doi: 10.3389/fgene.2022.851390
Figure Legend Snippet: Significant changes of CBX expression in the transcription level between ESCA and normal esophagus tissues (ONCOMINE).
Techniques Used: Expressing
Figure Legend Snippet: Protein expression levels of CBX1, CBX3, CBX7, and CBX8 in 12 ESCA tissues and adjacent normal tissues (western blot). (A) CBX1, CBX3, and CBX8 were upregulated in ESCA tissues compared with adjacent normal tissues, while CBX7 was expressed at similar levels in ESCA and normal esophageal tissues. (B–E) Statistical results of western blotting of CBX1, CBX3, CBX7, and CBX8 in ESCA tissues and normal tissues. (* p < 0.05, analysis by paired t-test.)
Techniques Used: Expressing, Western Blot
Figure Legend Snippet: Fluorescence images of paraffin-embedded sections of human ESCA and adjacent tissues with confocal microscopy. (A) CBX1 was significantly higher in ESCA tissues than that in precancerous tissues. (B) CBX3 was significantly higher in ESCA tissues than that in precancerous tissues. (C) CBX8 was significantly higher in ESCA tissues than that in precancerous tissues. The white dashed lines separate the precancerous tissues (on the left side of the figure) from the ESCA tissues (on the right side of the figure). Scale bars = 25 um. (Magnification 63✕/1.40 oil).
Techniques Used: Fluorescence, Confocal Microscopy
Related Articles
Expressing:Article Title: Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer Article Snippet: Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).. Primary antibodies used in this study were as follows: CBX1 Polyclonal Antibody (Proteintech, 10241-2 -AP), CBX3 Polyclonal Antibody ( Western Blot:Article Title: Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer Article Snippet: Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).. Primary antibodies used in this study were as follows: CBX1 Polyclonal Antibody (Proteintech, 10241-2 -AP), CBX3 Polyclonal Antibody ( Fluorescence:Article Title: Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer Article Snippet: Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).. Primary antibodies used in this study were as follows: CBX1 Polyclonal Antibody (Proteintech, 10241-2 -AP), CBX3 Polyclonal Antibody ( Confocal Microscopy:Article Title: Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer Article Snippet: Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).Proteins were separated by SDS-PAGE and were visualized using the ECL system (Bio-Rad, Hercules, CA, United States).. Primary antibodies used in this study were as follows: CBX1 Polyclonal Antibody (Proteintech, 10241-2 -AP), CBX3 Polyclonal Antibody ( |

